Severe acute respiratory syndrome

被引：149

作者：

Christian, MD

Poutanen, SM

Loutfy, MR

Muller, MP

Low, DE

机构：

[1] Mt Sinai Hosp, Dept Microbiol, Toronto, ON M5G 1X5, Canada

[2] Univ Hlth Network, Toronto Gen Hosp, Toronto, ON, Canada

[3] Toronto Med Labs, Toronto, ON, Canada

[4] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada

[5] Univ Toronto, Dept Med, Toronto, ON, Canada

[6] McGill Univ, Dept Med, Montreal, PQ, Canada

来源：

CLINICAL INFECTIOUS DISEASES | 2004年 / 38卷 / 10期

关键词：

D O I：

10.1086/420743

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The first cases of severe acute respiratory syndrome (SARS) occurred in China in November 2002. The agent causing this illness has been identified as a novel coronavirus, SARS-coronavirus. Since its introduction <1 year ago, this virus has infected 8098 people in 26 countries, killing 774 of them. We present an overview of the epidemiology, clinical presentation, diagnosis, and treatment of SARS based on the current state of knowledge derived from published studies and our own personal experience.

引用

页码：1420 / 1427

页数：8

共 69 条

[1]

*AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801

[2]

[Anonymous], 2004, SUMMARY PROBABLE SAR

[3] Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases [J].

Ballow, M .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 100 (02) :151-157

[4]

Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954

[5] Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area [J].

Booth, CM ;

Matukas, LM ;

Tomlinson, GA ;

Rachlis, AR ;

Rose, DB ;

Dwosh, HA ;

Walmsley, SL ;

Mazzulli, T ;

Avendano, M ;

Derkach, P ;

Ephtimios, IE ;

Kitai, I ;

Mederski, BD ;

Shadowitz, SB ;

Gold, WL ;

Hawryluck, LA ;

Rea, E ;

Chenkin, JS ;

Cescon, DW ;

Poutanen, SM ;

Detsky, AS .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (21) :2801-2809

[6]

*CDCP, 2003, MMWR-MORBID MORTAL W, V52, P241

[7]

Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P1202

[8]

Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P405

[9]

Chan K. S., 2003, Hong Kong Medical Journal, V9, P399

[10] SARS: prognosis, outcome and sequelae [J].

Chan, KS ;

Zheng, JP ;

Mok, YW ;

Li, YM ;

Liu, YN ;

Chu, CM ;

Ip, MS .

RESPIROLOGY, 2003, 8 :S36-S40

← 1 2 3 4 5 6 7 →